Current therapies can fall short in effectively treating chronic elbow OA.1
Certain treatments can be associated with systemic side effects (GI, renal, chondrotoxic)
Daily administration or multiple injections can be inconvenient and can lead to pet parent noncompliance
Many treatments are short-acting and only designed to address acute pain and inflammation, not the ongoing pain of elbow OA
Treatments may only target specific pathway receptors, but don’t suppress the transduction phase of the pain pathway
There is uncertain efficacy with some approaches, especially supplements and unapproved products, which have limited or no evidence-based data
Reference: 1. Bland SD. Canine osteoarthritis and treatments: a review. Veterinary Science Development. 2015;5(2):84-89. DOI: 10.4081/vsd.2015.5931.